Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra LifeSciences Reports First Quarter 2025 Financial Results
06:30am, Monday, 05'th May 2025
PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first
Burn Care Market worth $3.35 billion by 2030 with 5.6% CAGR | MarketsandMarkets™
10:15am, Friday, 02'nd May 2025
DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Burn Care Market, valued at US$2.46 billion in 2024, is forecasted to grow at a robust CAGR of 5.6%, reaching US$2.55 billion in 2025 and an
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
04:30pm, Friday, 18'th Apr 2025
PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial re
Is This the Right Time to Hold Integra Stock in Your Portfolio?
09:35am, Wednesday, 26'th Mar 2025
IART stays on investors' radar courtesy of its strong prospects in the CSS segment and international growth.
Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf
12:10pm, Saturday, 22'nd Mar 2025
PHILADELPHIA, March 22, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
05:00pm, Thursday, 13'th Mar 2025
PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief exe
Integra LifeSciences: Light At The End Of The Tunnel, Or Another Oncoming Train? (Rating Upgrade)
07:23am, Thursday, 06'th Mar 2025
Integra LifeSciences had a rough 2024 as the company's quality control remediation efforts had a bigger than expected negative impact on results. Q4 '24 offered some stability with organic revenue gro
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up
10:06am, Monday, 03'rd Mar 2025
IART delivers better-than-expected earnings in the fourth quarter of 2024.
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Integra LifeSciences Holdings Co
Integra LifeSciences Holdings Corporation (IART) Q4 2024 Earnings Call Transcript
10:50am, Tuesday, 25'th Feb 2025
Integra LifeSciences Holdings Corporation (IART) Q4 2024 Earnings Call Transcript
Integra (IART) Reports Q4 Earnings: What Key Metrics Have to Say
10:35am, Tuesday, 25'th Feb 2025
Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stre
Integra LifeSciences (IART) Surpasses Q4 Earnings Estimates
08:15am, Tuesday, 25'th Feb 2025
Integra LifeSciences (IART) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.89 per share a year ago.
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
06:00am, Tuesday, 25'th Feb 2025
PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 202
Jan De Witte joins GHO Capital as Operating Partner
04:30am, Tuesday, 11'th Feb 2025
Jan De Witte joins GHO Capital as Operating Partner Former CEO of Integra LifeSciences with significant strategic and operational experience to support GHO Capital's portfolio London, UK – 11 Februa
PHILADELPHIA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties
